Skip to Content

WPI 39 70 (Metronidazole 500 mg)

Pill with imprint WPI 39 70 is White, Capsule-shape and has been identified as Metronidazole 500 mg. It is supplied by Watson Pharmaceuticals, Inc..

Metronidazole is used in the treatment of bacterial infection; amebiasis; aspiration pneumonia; bacteremia; bacterial vaginitis and belongs to the drug classes amebicides, miscellaneous antibiotics. There is no proven risk in humans during pregnancy. Metronidazole 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 39 70

Metronidazole 500 mg WPI 39 70
Metronidazole 500 mg WPI 39 70
Metronidazole 500 mg WPI 39 70
Metronidazole 500 mg WPI 39 70
Metronidazole 500 mg WPI 39 70

Metronidazole

Imprint
WPI 39 70
Strength
500 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Amebicides, Miscellaneous antibiotics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals, Inc.
National Drug Code (NDC)
00591-3970

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.